Assessing Risks of Polypharmacy Involving Medications With Anticholinergic Properties.

CONCLUSIONS: The ACB was associated with adverse outcomes in a middle- to older-aged population. Populations identified and effect size differed between scales. Scale choice influenced the population identified as potentially requiring reduction in ACB in clinical practice or intervention trials.
PMID: 32152019 [PubMed - in process]

Source: Annals of Family Medicine - February 29, 2020 Category: Primary Care Authors: Hanlon P, Quinn TJ, Gallacher KI, Myint PK, Jani BD, Nicholl BI, Lowrie R, Soiza RL, Neal SR, Lee D, Mair FS Tags: Ann Fam Med Source Type: research